Hazard functions for each health state transition estimated using a Bayesian multi-state network meta-analyis (NMA).
mstate_nma_hazard
A data.table with the following columns:
Line of treatment. Either first or second.
At 2nd line, equal to 1 if there is a T790M mutation and 0 otherwise.
The statistical model.
Name of the treatment.
Trial month.
The health state transition.
Mean hazard from the posterior distribution.
Median hazard from the posterior distribution.
Lower limit of 95 percent credible interval from posterior distribution.
Upper limit of the 95 percent credible interval from the posterior distribution.
head(mstate_nma_hazard)#> line mutation model tx_name month transition mean #> 1: 1 NA Weibull erlotinib 0 Stable to progression 0.00000000 #> 2: 1 NA Weibull erlotinib 1 Stable to progression 0.01856030 #> 3: 1 NA Weibull erlotinib 2 Stable to progression 0.02333390 #> 4: 1 NA Weibull erlotinib 3 Stable to progression 0.02718846 #> 5: 1 NA Weibull erlotinib 4 Stable to progression 0.03056072 #> 6: 1 NA Weibull erlotinib 5 Stable to progression 0.03362348 #> median l95 u95 #> 1: 0.00000000 0.000000000 0.00000000 #> 2: 0.01669442 0.006649992 0.04093952 #> 3: 0.02203804 0.011704229 0.04221888 #> 4: 0.02636427 0.014921971 0.04643930 #> 5: 0.02973639 0.016256593 0.05189522 #> 6: 0.03244486 0.017186136 0.05676506